Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.55 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.52 |
| ▸ | PPARA | Q07869 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.49 |
| ▸ | ESR1 | P03372 | 2/20 | 0.49 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.49 |
| ▸ | TACR2 | P21452 | 2/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | SHBG | P04278 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.49 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.49 |
| ▸ | HTR2C | P28335 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2283968 | 1.00 | CDK1 (0.55) | CDK1KAT8PPARAPTGS2ESR1 | |
| SCHEMBL510844 | 1.00 | CDK1 (0.55) | CDK1KAT8PPARAPTGS2ESR1 | |
| SCHEMBL30561840 | 1.00 | CDK1 (0.55) | CDK1KAT8PPARAPTGS2ESR1 | |
| SCHEMBL29731119 | 1.00 | CDK1 (0.55) | CDK1KAT8PPARAPTGS2ESR1 | |
| SCHEMBL3894996 | 1.00 | CDK1 (0.55) | CDK1KAT8PPARAPTGS2ESR1 | |
| SCHEMBL6689622 | 1.00 | CDK1 (0.55) | CDK1KAT8PPARAPTGS2ESR1 | |
| SCHEMBL2278630 | 1.00 | CDK1 (0.55) | CDK1KAT8PPARAPTGS2ESR1 | |
| SCHEMBL2279414 | 1.00 | CDK1 (0.55) | CDK1KAT8PPARAPTGS2ESR1 | |
| SCHEMBL6691210 | 1.00 | CDK1 (0.55) | CDK1KAT8PPARAPTGS2ESR1 | |
| SCHEMBL6689618 | 1.00 | CDK1 (0.55) | CDK1KAT8PPARAPTGS2ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 502 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260135180-A1 | SEPARATION OF METALS FROM LITHIUM-ION BATTERY MATERIALS | UCHICAGO ARGONNE, LLC (US) | 2026-05-14 | — | — | US | claimed |
| CN-122012923-A | Extraction system and method for preparing lithium phosphate products | 中国恩菲工程技术有限公司 | 2026-05-12 | — | — | CN | claimed |
| WO-2025132786-A1 | CONTINUOUS PROCESS AND PRODUCTION PLANT FOR PREPARING ACIDIC AQUEOUS METAL SOLUTIONS | BASF SE (DE) | 2025-06-26 | — | — | WO | claimed |
| US-12180561-B2 | Methods for extracting elements from a solution | BASF CORPORATION (US) | 2024-12-31 | — | — | US | claimed |
| CN-116062784-B | Preparation method of high-purity calcium fluoride | 大连理工大学 | 2024-10-22 | — | — | CN | claimed |
| CN-118718469-A | Safe and efficient extracting agent for removing phenol and oil and application thereof | 中国科学院过程工程研究所 | 2024-10-01 | — | — | CN | claimed |
| CN-118619314-A | Method for preparing battery-grade lithium compound | 杭州隆硕科技有限公司 | 2024-09-10 | — | — | CN | claimed |
| CN-115970653-B | Preparation of purifying and impurity-removing resin for lithium ion battery leaching liquid and impurity-removing method thereof | 西安建筑科技大学 | 2024-06-25 | — | — | CN | claimed |
| CN-117926004-B | Preparation method and application of metal extractant for recycling lithium battery anode material | 金族(兰州)精细化工有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117926004-A | Preparation method and application of metal extractant for recycling lithium battery anode material | 天津崇研科技有限公司 | 2024-04-26 | — | — | CN | claimed |
| EP-0085522-B1 | SOLVENT EXTRACTION | HENKEL CORPORATION (a Delaware corp.) (US) | 1989-04-26 | — | — | EP | claimed |
| EP-0247728-A1 | Corrosion inhibiting composition and process | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-12-02 | — | — | EP | claimed |
| EP-0238629-A1 | COMPOSITION COMPRISING A TRANSITION METAL OR LEAD COMPLEX OF A MANNICH BASE AND AN OXIM AND ITS USE AS A FUEL ADDITIVE. | LUBRIZOL CORP (US) | 1987-09-30 | — | — | EP | claimed |
| US-4673412-A | STORAGE STABILITY | THE LUBRIZOL CORPORATION (US) | 1987-06-16 | — | — | US | claimed |
| WO-1987001720-A1 | FUEL ADDITIVE COMPRISING A METAL COMPOUND AND AN OXIME AND FUEL COMPOSITIONS CONTAINING SAME | THE LUBRIZOL CORPORATION (US) | 1987-03-26 | — | — | WO | claimed |
| EP-0186882-A1 | Solvent extraction process for recovery of zinc | HENKEL CORPORATION (a Delaware corp.) (US) | 1986-07-09 | — | — | EP | claimed |
| US-4563256-A | Solvent extraction process for recovery of zinc | HENKEL CORPORATION (US) | 1986-01-07 | — | — | US | claimed |
| US-4336231-A | CONTACTING THE COMPLEX WITH A MINERAL ACID AND SEPARATING THE SOLVENT PHASE | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1982-06-22 | — | — | US | claimed |
| US-4231888-A | CHELATION WITH AN O-HYDROXYARYLOXIME IN THE PRESENCE OF AN ALKYLPHENOL | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-11-04 | — | — | US | claimed |
| US-4142952-A | COPPER EXTRACTION WITH SALICYLALDOXIME-P-NONYLPHENOL MIXTURES | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1979-03-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260135180-A1 | SEPARATION OF METALS FROM LITHIUM-ION BATTERY MATERIALS | KMO, B2M, MAP2K5 | CDK1 1928/4885KAT8 1920/4885PPARA 1432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.